Excess Costs Associated with Possible Misdiagnosis of Alzheimer’s Disease among Patients with Vascular Dementia in a UK CPRD Population
Manuscript Number:
15-0685R2
Author(s):
Mark Belger, Howard G. Birnbaum, Urvi Desai, Michael Happich, Sarah King, Noam Y. Kirson, Alan Lenox-Smith, David Price, Catherine C. Reed
Disclosures
Mark Belger
Equity:
I have shares in Eli Lilly
Sponsors:
I am a full time employee of Eli Lilly
Howard G. Birnbaum
Consulting Fees:
I am an employee of Analysis Group, Inc., an economic and healthcare consulting firm. Analysis Group received research support for this project from Eli Lilly
Urvi Desai
Consulting Fees:
I am an employee of Analysis Group, Inc., an economic and healthcare consulting firm. Analysis Group received research support for this project from Eli Lilly
Michael Happich
Equity:
I have Lilly stocks.
Sponsors:
I am employee at Eli Lilly.
Sarah King
Consulting Fees:
I am an employee of Analysis Group, Inc., an economic and healthcare consulting firm. Analysis Group received research support for this project from Eli Lilly
Noam Y. Kirson
Consulting Fees:
I am an employee of Analysis Group, Inc., an economic and healthcare consulting firm. Analysis Group received research support for this project from Eli Lilly.
Grants
Agency:
Eli Lilly and Co.
Dates:
2014-2015
Alan Lenox-Smith
Equity:
I own some shares in Lilly
Sponsors:
I am a fully time employee of Lilly
David Price
Consulting Fees:
Consultancy- fees paid to Research in Real Life Ltd
Almirall, Amgen Inc, AstraZeneca plc, Boehringer Ingelheim, Chiesi, GlaxoSmithKline plc, Meda, Mundipharma, Napp, Novartis International AG, Pfizer, Inc. and Teva
Equity:
has shares in AKL Ltd which produces phytopharmaceuticals. I own 80% of Research in Real Life Ltd and its subsidiary social enterprise Optimum Patient Care
Lecture Fees:
Lectures/ speaking engagements- fees paid to Research in Real Life Ltd
Almirall, AstraZeneca plc, Boehringer Ingelheim, Chiesi, Cipla, GlaxoSmithKline plc, Kyorin, Meda, Merck & Co., Inc, Mundipharma, Novartis International AG, Pfizer, Inc., SkyePharma, Takeda, and Teva
Patents/Royalties
AKL Ltd. - Phytopharmaceuticals
Grants
Agency:
UK National Health Service, British Lung Foundation